ACE Reports.
Make a selection below to explore our full database of 9 results on the topic: "JY Reginster"
ACE Reports
(9 Reports)ACE Reports
(9 Reports)
Metabolic Disorders
Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
Osteoarthritis
Glucosamine sulfate reduced knee OA incidence in overweight females at 2.5 years
Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S42-8
Metabolic Disorders
WCO-IOF 2016: Denosumab versus zoledronic acid following oral bisphosphonate therapy
General Orthopaedics
WCO-IOF: Vitamin D supplementation appears to improve muscle function
General Orthopaedics
Collagen hydrolysate supplements may improve articular pain
Complement Ther Med. 2012 Jun;20(3):124-30. doi: 10.1016/j.ctim.2011.12.007. Epub 2012 Jan 20
Osteoarthritis
Knee OA: Single (1200 mg) and 3/day (400 mg) dose chondroitin are equivalent
Osteoarthritis Cartilage. 2012 Oct 8. pii: S1063-4584(12)00992-2. doi: 10.1016/j.joca.2012.09.017
Metabolic Disorders
Denosumab increases bone mineral density in male patients with low BMD
J Clin Endocrinol Metab. 2012 Sep;97(9):3161-9. doi: 10.1210/jc.2012-1569. Epub 2012 Jun 21
Metabolic Disorders
Zoledronic acid in the prevention and treatment of glucocorticoid-induced osteoporosis
Lancet. 2009 Apr 11;373(9671):1253-63
Osteoarthritis
Glucosamine sulphate for 12 months reduces relative risk of TJR at a 5 year follow-up
Osteoarthritis Cartilage. 2008 Feb;16(2):254-60